{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:31:20Z","timestamp":1791592280449,"version":"4.3.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Clinical Research Plan of SHDC","award":["No. SHDC2020CR3079B"],"award-info":[{"award-number":["No. SHDC2020CR3079B"]}]},{"name":"Shanghai Municipal Key Clinical Specialty","award":["shslczdzk03401"],"award-info":[{"award-number":["shslczdzk03401"]}]},{"DOI":"10.13039\/501100008838","name":"Shanghai Municipal Commission of Economy and Informatization","doi-asserted-by":"publisher","award":["201901014"],"award-info":[{"award-number":["201901014"]}],"id":[{"id":"10.13039\/501100008838","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-023-10264-4","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T19:03:00Z","timestamp":1702926180000},"page":"4550-4560","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The earliest optimal timing for total-body 68Ga-fibroblast activation protein inhibitor-04 PET scans: an evidence-based single-centre study"],"prefix":"10.1007","volume":"34","author":[{"given":"Zhe","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wujian","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4813-4262","authenticated-orcid":false,"given":"Hongcheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"key":"10264_CR1","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","volume":"47","author":"HJ Chen","year":"2020","unstructured":"Chen HJ, Pang YZ, Wu JX et al (2020) Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging 47:1820\u20131832","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10264_CR2","volume":"60:801-805","author":"C Kratochwil","year":"2019","unstructured":"Hathi DK, Jones EF (2019) [(68)Ga]Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer. Radiol Imaging Cancer 1:e194003","journal-title":"J Nucl Med"},{"key":"10264_CR3","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1097\/RLU.0000000000004073","volume":"47","author":"TF \u00c7ermik","year":"2022","unstructured":"\u00c7ermik TF, Erg\u00fcl N, Y\u0131lmaz B, Mercano\u011flu G (2022) Tumor imaging with 68Ga-DOTA-FAPI-04 PET\/CT: comparison with 18F-FDG PET\/CT in 22 different cancer types. Clin Nucl Med 47:e333\u2013e339","journal-title":"Clin Nucl Med"},{"key":"10264_CR4","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1007\/s00259-021-05475-0","volume":"48","author":"M Sollini","year":"2021","unstructured":"Sollini M, Kirienko M, Gelardi F, Fiz F, Gozzi N, Chiti A (2021) State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 48:4396\u20134414","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10264_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-06004-3","author":"RH Chen","year":"2022","unstructured":"Chen RH, Yang XL, Yu XF et al (2022) The feasibility of ultra-early and fast total-body [(68) Ga]Ga-FAPI-04 PET\/CT scan. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-022-06004-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10264_CR6","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1007\/s00259-020-05146-6","volume":"48","author":"L Zhao","year":"2021","unstructured":"Zhao L, Pang YZ, Luo ZM et al (2021) Role of [(68)Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of peritoneal carcinomatosis and comparison with [(18)F]-FDG PET\/CT. Eur J Nucl Med Mol Imaging 48:1944\u20131955","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10264_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00259-020-04843-6","volume":"48","author":"A Dimitrakopoulou-Strauss","year":"2021","unstructured":"Dimitrakopoulou-Strauss A, Pan L, Sachpekidis C (2021) Kinetic modeling and parametric imaging with dynamic PET for oncological applications: general considerations, current clinical applications, and future perspectives. Eur J Nucl Med Mol Imaging 48:21\u201339","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10264_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.651005","volume":"11","author":"SL Wang","year":"2021","unstructured":"Wang SL, Zhou X, Xu XX et al (2021) Dynamic PET\/CT imaging of 68Ga-FAPI-04 in Chinese subjects. Front Oncol 11:651005","journal-title":"Front Oncol"},{"key":"10264_CR9","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s00259-020-05132-y","volume":"48","author":"S Ballal","year":"2021","unstructured":"Ballal S, Yadav MP, Moon ES et al (2021) Biodistribution, pharmacokinetics, dosimetry of [(68)Ga]Ga-DOTA.SA.FAPI, and the head-to-head comparison with [(18)F]F-FDG PET\/CT in patients with various cancers. Eur J Nucl Med Mol Imaging 48:1915\u20131931","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10264_CR10","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s00259-021-05266-7","volume":"48","author":"J Ferdinandus","year":"2021","unstructured":"Ferdinandus J, Kessler L, Hirmas N et al (2021) Equivalent tumor detection for early and late FAPI-46 PET acquisition. Eur J Nucl Med Mol Imaging 48:3221\u20133227","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10264_CR11","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1007\/s00259-021-05646-z","volume":"49","author":"KZ Hu","year":"2022","unstructured":"Hu KZ, Wang LJ, Wu HB et al (2022) [(18)F]FAPI-42 PET imaging in cancer patients: optimal acquisition time, biodistribution, and comparison with [(68)Ga]Ga-FAPI-04. Eur J Nucl Med Mol Imaging 49:2833\u20132843","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10264_CR12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264069","author":"FM Glatting","year":"2022","unstructured":"Glatting FM, Hoppner J, Liew DP et al (2022) Repetitive early FAPI-PET acquisition comparing FAPI-02, FAPI-46 and FAPI-74: methodological and diagnostic implications for malignant, inflammatory and degenerative lesions. J Nucl Med. https:\/\/doi.org\/10.2967\/jnumed.122.264069","journal-title":"J Nucl Med"},{"key":"10264_CR13","first-page":"127","volume":"63","author":"R Manuel","year":"2021","unstructured":"Manuel R, Dominik L, Glatting Frederik M et al (2021) Fibroblast activation protein specific PET\/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study. J Nucl Med 63:127\u2013133","journal-title":"J Nucl Med"},{"key":"10264_CR14","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1007\/s00259-020-05091-4","volume":"48","author":"H Tan","year":"2021","unstructured":"Tan H, Sui XL, Yin HY et al (2021) Total-body PET\/CT using half-dose FDG and compared with conventional PET\/CT using full-dose FDG in lung cancer. Eur J Nucl Med Mol Imaging 48:1966\u20131975","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10264_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40658-022-00474-y","volume":"9","author":"YB He","year":"2022","unstructured":"He YB, Gu YS, Yu HJ et al (2022) Optimizing acquisition times for total-body positron emission tomography\/computed tomography with half-dose (18)F-fluorodeoxyglucose in oncology patients. EJNMMI Phys 9:45","journal-title":"EJNMMI Phys"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10264-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-023-10264-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10264-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T08:06:43Z","timestamp":1719562003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-023-10264-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,18]]},"references-count":15,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["10264"],"URL":"https:\/\/doi.org\/10.1007\/s00330-023-10264-4","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,18]]},"assertion":[{"value":"28 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Hongcheng Shi.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The Institutional Review Board of the Zhongshan Hospital, Fudan University, approved this study (study number: B2022-098R2).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No study subjects or cohorts have been previously reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 Prospective\u2022 Observational\u2022 Performed at one institution","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}